RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
NDT Pharmaceuticals Stock

NDT Pharmaceuticals P/E 2024

NDT Pharmaceuticals P/E

0

Ticker

NDTP

ISIN

US63948Q1058

As of Sep 21, 2024, NDT Pharmaceuticals's P/E ratio was 0, a 0% change from the 0 P/E ratio recorded in the previous year.

The NDT Pharmaceuticals P/E history

NDT Pharmaceuticals Aktienanalyse

What does NDT Pharmaceuticals do?

NDT Pharmaceuticals Inc is an American company that has been operating in the pharmaceutical industry for over 30 years. It was founded in 1989 by Robert Dickey and is headquartered in New Jersey. The company's focus is on the development and production of prescription drugs, as well as the manufacturing of raw materials for the pharmaceutical industry. The history of NDT Pharmaceuticals Inc dates back to its founding in 1989. Robert Dickey, the company's founder, began his career in the pharmaceutical sector in the 1970s and built his success with The Pharmaceutical Research Institute. This company was later acquired by Pfizer, and in 1989 Dickey joined NDT Pharmaceuticals Inc. At that time, the company had no products and employed only a few people. However, through the dedicated work and innovative ability of Robert Dickey and his team, the company quickly grew and became a major player in the American pharmaceutical market. The business model of NDT Pharmaceuticals Inc is focused on developing prescription drugs and successfully placing them in the market. The company relies on close collaboration with doctors and other medical professionals to best understand and meet the needs of patients. At the same time, the company heavily invests in research and development to stay up to date with the latest medical knowledge and be able to bring innovative products to the market. The company is divided into different divisions to concentrate its focus on various product parameters and meet the needs of patients. These divisions include Hoppliedarkton, which offers products for pain relief and inflammation; Sleepoprofen, which develops and produces medications to support healthy sleep; and Revitalix, which offers products to enhance quality of life based on natural ingredients such as vitamins and antioxidants. Throughout its history, NDT Pharmaceuticals Inc has brought a variety of products to the market aimed at improving health. Some of these products include Naprogesic, a medication for pain treatment during menstruation; Vivenza, an over-the-counter medication for treating sleep disorders; and Revitalift, a highly effective anti-aging complex based on natural plant extracts and vitamins. In conclusion, NDT Pharmaceuticals Inc has established an excellent reputation as a reliable provider of prescription drugs and raw materials for the pharmaceutical industry since its founding. The company relies on close collaboration with medical professionals and a high investment in research and development to develop innovative and effective products. With its different divisions and products, the company aims to improve the health and well-being of its patients. NDT Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering NDT Pharmaceuticals's P/E Ratio

The Price to Earnings (P/E) Ratio of NDT Pharmaceuticals is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing NDT Pharmaceuticals's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of NDT Pharmaceuticals is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in NDT Pharmaceuticals’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about NDT Pharmaceuticals stock

What is the price-to-earnings ratio of NDT Pharmaceuticals?

The price-earnings ratio of NDT Pharmaceuticals is currently 0.

How has the price-earnings ratio of NDT Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of NDT Pharmaceuticals has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of NDT Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of NDT Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of NDT Pharmaceuticals affect the company?

An increase in the price-earnings ratio of NDT Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of NDT Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of NDT Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of NDT Pharmaceuticals?

Some factors that influence the price-earnings ratio of NDT Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does NDT Pharmaceuticals pay?

Over the past 12 months, NDT Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, NDT Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of NDT Pharmaceuticals?

The current dividend yield of NDT Pharmaceuticals is .

When does NDT Pharmaceuticals pay dividends?

NDT Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of NDT Pharmaceuticals?

NDT Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of NDT Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is NDT Pharmaceuticals located?

NDT Pharmaceuticals is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von NDT Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of NDT Pharmaceuticals from 9/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/21/2024.

When did NDT Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/21/2024.

What was the dividend of NDT Pharmaceuticals in the year 2023?

In the year 2023, NDT Pharmaceuticals distributed 0 USD as dividends.

In which currency does NDT Pharmaceuticals pay out the dividend?

The dividends of NDT Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von NDT Pharmaceuticals

Our stock analysis for NDT Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NDT Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.